OTC Markets Group Welcomes Organto Foods Inc. to OTCQX

OTC Markets Group Welcomes Organto Foods Inc. to OTCQX GlobeNewswire November 10, 2025 NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Organto Foods Inc. (TSX-V: OGO; FSE: OGF0; OTCQX: OGOFF), an integrated provider of organic and […]

Lotus Technology to Report Unaudited Third Quarter 2025 Financial Results on November 24, 2025

Lotus Technology to Report Unaudited Third Quarter 2025 Financial Results on November 24, 2025 GlobeNewswire November 10, 2025 NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — Lotus Technology Inc. (“Lotus” or the “Company”) (Nasdaq: LOT), a leading global intelligent and luxury mobility provider, today announced that it will report its unaudited financial results for the

Alpha Modus and OptiSigns Settle Lawsuit

Alpha Modus and OptiSigns Settle Lawsuit GlobeNewswire November 10, 2025 CORNELIUS, N.C. and HOUSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) — Alpha Modus, Corp. (“Alpha Modus”), the subsidiary of Alpha Modus Holdings, Inc. (NASDAQ:AMOD), today announced today that it has resolved its patent infringement lawsuit against OptiSigns, Inc. The case was concluded on November 4, 2025,

Immunocore to present at upcoming investor conferences

Immunocore to present at upcoming investor conferences GlobeNewswire November 10, 2025 (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, November 10, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases,

Cullinan Therapeutics to Participate in Upcoming Investor Conferences and Host Analyst and Investor Event at 2025 ASH Annual Meeting

Cullinan Therapeutics to Participate in Upcoming Investor Conferences and Host Analyst and Investor Event at 2025 ASH Annual Meeting GlobeNewswire November 10, 2025 CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company accelerating potential high-impact therapies in autoimmune diseases and cancer, today announced its management team will

Fury Drilling at Committee Bay Extends Three Bluffs Mineralization and Expands Raven Target

(TSX:FURY),(NYSE MKT:FURY), TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company“) announces the results from the 2025 exploration drilling program at the Committee Bay project, located in the eastern Kitikmeot region of Nunavut, Canada (Figure 1). The 2025 drilling program comprised six (6) diamond

Fury Drilling at Committee Bay Extends Three Bluffs Mineralization and Expands Raven Target

Fury Drilling at Committee Bay Extends Three Bluffs Mineralization and Expands Raven Target GlobeNewswire November 10, 2025 TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company“) announces the results from the 2025 exploration drilling program at the Committee Bay project, located in the eastern

Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the third quarter ended September 30, 2025, and provided a review of recent accomplishments and anticipated upcoming

TreeHouse Foods and Investindustrial Announce Definitive Acquisition Agreement for a Total Enterprise Value of $2.9 Billion

TreeHouse Foods Shareholders to Receive $22.50 Per Share in Cash and One Contingent Value Right Per Share TreeHouse Foods, Inc. (NYSE: THS, “TreeHouse Foods” or “the Company”) and Industrial F&B Investments III Inc. (“Investindustrial”), an independently managed investment subsidiary of Investindustrial VIII SCSp, part of a leading European group of independently managed investment, holding, and

Scroll to Top